"
Team:SupBiotech-Paris/Bibliographie
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 27: | Line 27: | ||
|height=40px|Thérapie genique | |height=40px|Thérapie genique | ||
|[1] | |[1] | ||
| - | | | + | |Kevin J. Scanlon and al. |
| - | | | + | |Cancer Gene Therapy: Challenges and Opportunities |
| - | | | + | |2004 |
|- style="background: #C0C0C0; text-align: center;" | |- style="background: #C0C0C0; text-align: center;" | ||
|height=40px|Thérapie genique | |height=40px|Thérapie genique | ||
|[2] | |[2] | ||
| - | | | + | |Gouze JN and al. |
| - | | | + | |A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer |
| - | | | + | |2003 |
|- style="background: white; text-align: center;" | |- style="background: white; text-align: center;" | ||
Revision as of 12:19, 20 October 2009
Projet
Introduction Thérapies actuelles Thérapies géniques Le DVS Concept Vecteur Tissulaire Vecteur Cellulaire Plasmide thérapeutique Conclusion Mise en application Ciblage Tissulaire Action antitumorale Modeling du traitement Conclusion
Ressources
BioBricks Matériel & Méthode Bibliographie
Ethique & sûreté
| Chapitre | Ref. | Auteurs | Titre | Année |
| Thérapie actuelle | [1] | Lechat P. | Pharmacology | 2006 |
| Thérapie actuelle | [2] | Bruguerolle B. | Biological rhythms and medications: a source of variability often neglected in pharmacology | 2008 |
| Thérapie genique | [1] | Kevin J. Scanlon and al. | Cancer Gene Therapy: Challenges and Opportunities | 2004 |
| Thérapie genique | [2] | Gouze JN and al. | A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer | 2003 |
| Thérapie génique | [3] | Centre for Genetics Education | http://www.genetics.com.au/index.asp | XXXX |
| Vectorisation | [1] | |||
| Vectorisation | [2] | |||
| Vectorisation | [3] | |||
| Vectorisation | [4] | |||
| Vectorisation | [5] | |||
| Vectorisation | [6] | |||
| Vectorisation | [7] | |||
| Vectorisation | [8] | |||
| Vectorisation | [9] | |||
| Vectorisation | [10] | |||
| Vectorisation | [11] | |||
| Vectorisation | [12] | |||
| Vectorisation | [13] | |||
| Vectorisation | [14] | |||
| Vectorisation | [15] | |||
| Vecteur Tissulaire | [1] | Ronald S. and al. | Antimicrobial mechanisms of phagocytes and bacterial evasion strategies | 2009 |
| Vecteur Tissulaire | [2] | Clark B. Inderlied and al. | The Mycobacterium avium Complex | 1993 |
| Vecteur Tissulaire | [3] | Nisheeth Agarwal and al. | Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase | 2009 |
| Vecteur Tissulaire | [4] | Hunter R.L. and al. | Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs | 2007 |
| Vecteur Tissulaire | [5] | Axelrod S and al. | Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide | 2008 |
| Vecteur Tissulaire | [6] | Nicole N van der Wel and al. | Subcellular localization of mycobacteria in tissues and detection of lipid antigens in organelles using cryo-techniques for light and electron microscopy | 2005 |
| Vecteur Tissulaire | [7] | Claudia Nobrega and al. | The thymus as a target for mycobacterial infections | 2007 |
| Vecteur Cellulaire | [1] | Harrison Echols and al. | Genetic Map of Bacteriophage Lambda | 1978 |
| Vecteur Cellulaire | [2] | Joseph Sambrook and al. | Molecular Cloning: A Laboratory Manual (Third Edition) | 2001 |
| Vecteur Cellulaire | [3] | Court DL and al. | A New Look at Bacteriophage lambda Genetic Networks | 2007 |
| Vecteur Cellulaire | [4] | Ortega ME and al. | Bacteriophage Lambda gpNu1 and Escherichia coli IHF Proteins Cooperatively Bind and Bend Viral DNA: Implications for the Assembly of a Genome-Packaging Motor | 2006 |
| Vecteur Cellulaire | [5] | Feiss M. and al. | Bactériophage Lambda Terminase and the Mechanism of Viral DNA Packaging | 2005 |
| Vecteur Cellulaire | [6] | Hang JQ and al. | The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB | 2001 |
| Vecteur Cellulaire | [7] | Becker A and al. | Bacteriophage lambda DNA : The begginning of the End | 1990 |
| Vecteur Cellulaire | [8] | Hochschild A and al. | The bactériophage lambda cI protein finds an asymmetric solution | 2009 |
| Vecteur Cellulaire | [9] | Phoebe L.Stewart1 and al. | Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization | 1997 |
| Plasmide thérapeutique | [1] | Ortega ME et al. | Bacteriophage lambda gpNu1 and Escherichia coli IHF proteins cooperatively bind and bend viral DNA: implications for the assembly of a genome-packaging motor | 2006 |
| Plasmide thérapeutique | [2] | Joseph Sambrook and al. | Molecular Cloning: A Laboratory Manual (Third Edition) | 2001 |
| Plasmide thérapeutique | [3] | Court DL and al. | A New Look at Bacteriophage lambda Genetic Networks | 2007 |
| Plasmide thérapeutique | [4] | Feiss M. and al. | Viral Genome Packaging Machines: Genetics, Structure and Mechanism | 2005 |
| Plasmide thérapeutique | [5] | Hang JQ and al. | The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB | 2001 |
| Plasmide thérapeutique | [6] | Becker A and al. | Bacteriophage lambda DNA : The begginning of the End | 1990 |
| Plasmide thérapeutique | [7] | Young et al. | Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature | 2003 |
| [] |
